BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow Quality Index
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Quality Index of 29.99x as of September 2025. Operating cash flow of Rs149.66 Million exceeds net income of Rs4.99 Million, indicating high earnings quality where cash backs reported profits. Explore BALAXI PHARMACEUTICALS LIMITED long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BALAXI PHARMACEUTICALS LIMITED Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for BALAXI PHARMACEUTICALS LIMITED across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BALAXI PHARMACEUTICALS LIMITED tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BALAXI PHARMACEUTICALS LIMITED (2013–2025)
Year-by-year earnings quality comparison for BALAXI PHARMACEUTICALS LIMITED. For live market cap and the full company financial profile, see BALAXI PHARMACEUTICALS LIMITED stock valuation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.51x | Rs-377.82 Million | Rs250.70 Million | ▼ -162.4% |
| 2024 | 2.41x | Rs48.66 Million | Rs20.15 Million | ▲ +2162.3% |
| 2023 | 0.11x | Rs60.75 Million | Rs569.22 Million | ▼ -83.0% |
| 2022 | 0.63x | Rs341.44 Million | Rs545.22 Million | ▲ +895421.0% |
| 2021 | 0.00x | Rs31.00K | Rs443.29 Million | ▲ +100.0% |
| 2020 | -1.58x | Rs-140.62 Million | Rs88.74 Million | ▼ -156.5% |
| 2019 | -0.62x | Rs-15.07 Million | Rs24.39 Million | ▼ -143.0% |
| 2015 | 1.44x | Rs2.11 Million | Rs1.47 Million | ▲ +165.7% |
| 2014 | -2.19x | Rs-2.39 Million | Rs1.10 Million | ▼ -129.8% |
| 2013 | 7.34x | Rs3.25 Million | Rs442.13K | — |